The Business First of Columbus [1] news publication reported that Ohio was ranked No. 11 in biopharmaceutical venture capital funding in an October study by the Milken Institute [2]. The study noted Ohio’s Third Frontier Project, a 10-year plan to spur the state’s high-tech economy, for increasing money spent on biotech. Massachusetts ranked No. 1 in the overall ranking, with Wyoming bringing coming in last.